In order to validate our findings in the RNA sequencing experiment, and examine whether the mRNA level of LCN2 could be altered by stroke, RNA were extracted from tumor tissues and quantitative real-time polymerase chain reaction (RT-PCR) was performed. The gene discussed is LCN2; the disease is neoplasm.